相关实验视频
Updated: Jun 18, 2025
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
心力衰竭中的血液吸收需要机械循环支持-系统性审查和元分析
Sebastian Freiburger1, Tulio Caldonazo1, Panagiotis Tasoudis2
1Department of Cardiothoracic Surgery, Jena University Hospital-Friedrich Schiller University of Jena, 07747 Jena, Germany.
Reviews in cardiovascular medicine
|July 30, 2024
概括
在心力衰竭的机械循环支持期间的血液吸收可能会增加LVAD的风险,并且在ECMO期间没有生存益处. 由于研究的局限性,需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 生物医学工程 生物医学工程
背景情况:
- 机械循环支持装置,如LVAD和ECMO对于心力衰竭 (HF) 至关重要.
- 这些设备可以加剧炎症,这是HF患者已知的危险因素.
- 在手术过程中探索血液吸收以减轻这种炎症.
研究的目的:
- 评估急性或慢性心力衰竭患者血液吸收的疗效.
- 评估其在与机械循环支持 (LVAD,ECMO) 一起使用时对生存的影响.
主要方法:
- 在MEDLINE的系统文献搜索中,对比血液吸收与LVAD植入或VA-ECMO期间的标准护理的研究进行系统的文献搜索.
- 两位独立调查人员对研究进行了选.
- 排除没有控制组的报告和重复条目.
主要成果:
- 包括6项研究:一项随机,五项追溯.
- 对于LVADs,一项研究没有显示死亡率差异,但增加了呼吸系统问题;另一项研究发现血液吸收的死亡率更高.
- 对于ECMO,大多数研究没有发现生存或不良事件的差异;一项小型研究报告说,血液吸收的死亡率较低.
结论:
- 在LVAD植入期间的血液吸收可能与增加的发病率和死亡率有关.
- 在VA-ECMO期间,血液吸收通常不会对死亡率或器官功能障碍产生影响.
- 受小样本大小和回顾性设计的限制,研究结果表明在这些环境中谨慎使用血液吸收.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:26Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555